Infection of HIV-1 transgenic mice with Mycobacterium avium induces the expression of infectious virus selectively from a Mac-1-positive host cell population

Journal of Immunology

Volumn 163, Issue 3, 1999, Pages 1506-1515

  Doherty, T Mark ^a,f   Chougnet, Claire ^c   Schito, Marco ^a   Patterson, Bruce K ^d   Fox, Cecil ^e   Shearer, Gene M ^c   Englund, George ^b   Sher, Alan ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e Molecular Histology Labs   (United States)

^f STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL POPULATION; HOST CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; IMMUNOPATHOGENESIS; MACROPHAGE; MOUSE; MYCOBACTERIUM AVIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; VIRION; VIRUS PATHOGENESIS;

EID: 0033179680     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Fauci, A. S. 1996. Host factors and the pathogenesis of HIV-induced disease. Nature 384:529.
2. Bentwich, Z., A. Kalinkovich, and Z. Weisman. 1995. Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol. Today 16:187.
3. Quinn, T. C., P. Piot, J. B. McCormick, F. M. Feinsod, H. Taelman, B. Kapita, W. Stevens, and A. S. Fauci. 1987. Serologic and immunologic studies in patients with AIDS in North America and Africa: the potential role of infectious agents as cofactors in human immunodeficiency virus infection. JAMA 257:2617.
4. Cantwell, M. F., and N. J. Binkin. 1997. Impact of HIV on tuberculosis in subSaharan Africa: a regional perspective. Int. J. Tuberc. Lung Dis. 1:205.
5. Goletti, D., D. Weissman, R. W. Jackson, N. M. Graham, D. Vlahov, R. S. Klein, S. S. Munsiff, L. Ortona, R. Cauda, and A. S. Fauci. 1996. Effect of Mycobacterium tuberculosis on HIV replication: role of immune activation. J. Immunol. 157:1271.
6. Whalen, C., C. R. Horsburgh, D. Hom, C. Lahart, M. Simberkoff, and J. Ellner. 1995. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am. J. Respir. Crit. Care Med. 151:129.
7. Munsiff, S. S., P. L. Alpert, M. N. Gourevitch, C. J. Chang, and R. S. Klein. 1998. A prospective study of tuberculosis and HIV disease progression. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 19:361.
8. Rosenberg, Z. F., and A. S. Fauci. 1989. Induction of expression of HIV in latently or chronically infected cells. AIDS Res. Hum. Retroviruses 5:1.
9. Poli, G., and A. S. Fauci. 1992. The effect of cytokines and pharmacologic agents on chronic HIV infection. AIDS Res. Hum. Retroviruses 8:191.
10. Dun, E. J., W. J. Maury, T. M. Folks, A. S. Fauci, and A. B. Rabson. 1989. Tumor necrosis factor α activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-κB sites in the long terminal repeat. Proc. Natl. Acad. Sci. USA 86:5974.
11. Toossi, Z., B. D. Hamilton, M. H. Phillips, L. E. Averill, J. J. Ellner, and A. Salvekar. 1997. Regulation of nuclear factor-κB and its inhibitor IκB-α/ MAD-3 in monocytes by Mycobacterium tuberculosis and during human tuberculosis. J. Immunol. 159:4109.
12. Gazzinelli, R. T., A. Sher, A. Cheever, S. Gerstberger, M. A. Martin, and P. Dickie. 1996. Infection of human immunodeficiency virus 1 transgenic mice with Toxoplasma gondii stimulates proviral transcription in macrophages in vivo. J. Exp. Med. 183:1645.
13. Meltzer, M. S., M. Nakamura, B. D. Hansen, J. A. Turpin, D. C. Kalter, and H. E. Gendelman. 1990. Macrophages as susceptible targets for HIV infection, persistent viral reservoirs in tissue, and key immunoregulatory cells that control levels of virus replication and extent of disease. AIDS Res. Hum. Retroviruses 6:967.
14. van Furth, R. 1989. Origin and turnover of monocytes and macrophages. Curr. Top. Pathol. 79:125.
15. Orenstein, J. M., C. Fox, and S. M. Wahl. 1997. Macrophages as a source of HIV during opportunistic infections. Science 276:1857.
16. Wahl, S. M., T. Greenwell-Wild, G. Peng, H. Hale-Donze, T. M. Doherty, D. Mizel, and J. M. Orenstein. 1998. Mycobacterium avium complex augments macrophage HIV-1 production and increases CCR5 expression. Proc. Natl. Acad. Sci. USA 95:12574.
17. Leonard, J. M., J. W. Abramczuk, D. S. Pezen, R. Rutledge, J. H. Belcher, F. Hakim, G. Shearer, L. Lamperth, W. Travis, T. Fredrickson, et al. 1988. Development of disease and virus recovery in transgenic mice containing HIV proviral DNA. Science 242:1665.
18. Denkers, E. Y., and R. T. Gazzinelli. 1998. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin. Microbiol. Rev. 11:569.
19. Dickie, P., R. Gazzinelli, and L. J. Chang. 1996. Models of HIV type 1 proviral gene expression in wild-type HIV and MLV/HIV transgenic mice. AIDS Res. Hum. Retroviruses 12:1103.
20. Doherty, T. M., and A. Sher. 1998. IL-12 promotes drug-induced clearance of Mycobacterium avium infection in mice. J. Immunol. 160:5428.
21. + T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J. Immunol. 149:175.
22. Waldeland, H., E. R. Pfefferkorn, and J. K. Frenkel. 1983. Temperature-sensitive mutants of Toxoplasma gondii: pathogenicity and persistence in mice. J. Parasitol 69:171.
23. Doherty, T. M., and A. Sher. 1997. Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection. J. Immunol. 158:4822.
24. Harada, S., Y. Koyanagi, and N. Yamamoto. 1985. Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229:563.
25. Freed, E. O., and M. A. Martin. 1994. Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120. J. Virol. 68:2503.
26. Fox, C. H., and M. Cottler-Fox. 1993. In situ hybridization for the detection of HIV RNA in cells and tissues. In Current Protocols in Immunology. J. Coligan, A. Kruisbeek, D. Margulies, E. Shevach, and W. Snober, eds. Wiley, New York.
27. Fox, C. H., S. Hoover, V. R. Currall, H. J. Bahre, and M. Cottler-Fox. 1994. HIV in infected lymph nodes. Nature 370:256.
28. Scott, P., P. Natovitz, R. L. Coffman, E. Pearce, and A. Sher. 1988. Immuno-regulation of cutaneous leishmaniasis: T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med. 168:1675.
29. Patterson, B. K., M. A. Czerniewski, J. Pottage, M. Agnoli, H. Kessler, and A. Landay. 1999. Monitoring HIV-1 treatment in immune-cell subsets with ultrasensitive fluorescence-in-situ hybridisation Lancet 353:211.
30. Bermudez, L. E., C. B. Inderlied, and L. S. Young. 1992. Mycobacterium avium complex in AIDS. Curr. Clin. Top. Infect. Dis. 12:257.
31. Chun, T. W., L. Carruth, D. Finzi, X. Shen, J. A. DiGiuseppe, H. Taylor, M. Hermankova, K. Chadwick, J. Margolick, T. C. Quinn, Y. H. Kuo, R. Brookmeyer, M. A. Zeiger, P. Barditch-Crovo, and R. F. Siliciano. 1997. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387:183.
32. + patients. Res. Virol. 147:115.
33. Embretson, J., M. Zupancic, J. L. Ribas, A. Burke, P. Racz, K. Tenner-Racz, and A. T. Haase. 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359.
34. Koenig, S., H. E. Gendelman, J. M. Orenstein, M. C. Dal Canto, G. H. Pezeshkpour, M. Yungbluth, F. Janotta, A. Aksamit, M. A. Martin, and A. S. Fauci. 1986. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 231:1089.
35. Wiley, C. A., R. D. Schrier, J. A. Nelson, P. W. Lampert, and M. B. Oldstone. 1986. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. USA 83:7089.
36. Schrager, L. K., and M. P. D'Souza. 1998. Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy. JAMA 280: 67.
37. Perno, C. F., F. M. Newcomb, D. A. Davis, S. Aquaro, R. W. Humphrey, R. Calio, and R. Yarchoan. 1998. Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus. J. Infect. Dis. 178:413.
38. Finzi, D., M. Hermankova, T. Pierson, L. M. Carruth, C. Buck, R. E. Chaisson, T. C. Quinn, K. Chadwick, J. Margolick, R. Brookmeyer, J. Gallant, M. Markowitz, D. D. Ho, D. D. Richman, and R. F. Siliciano. 1997. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278:1295.
39. Wong, J. K., M. Hezareh, H. F. Gunthard, D. V. Havlir, C. C. Ignacio, C. A. Spina, and D. D. Richman. 1997. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278:1291.